Register for our free email digests:
Javelin Pharmaceuticals Inc.
Division of Pfizer Inc.
www.javelinpharmaceuticals.com
Latest From Javelin Pharmaceuticals Inc.
Distortion And Inflation In Measuring Pharma M&A
Five companies in big pharma’s top 20 have come through mergers in the past 10 years or so that changed them significantly. As measured by standard financial performance parameters, the processes at Takeda and Teva (and to some extent, at Allergan) seem relatively smooth and productive. Those at Pfizer and Merck don’t. But it depends on how you look at the numbers.
A Busy Year-End, In Brief: December Brings Slate Of Approvals, And Setbacks
In addition to a spate of FDA approvals closing out the year, Roche contended with trial failures and Actavis received a “complete response” letter for its nebivolol/valsartan combination.
Asmacure appoints Martin Driscoll CEO
Asmacure, a clinical-stage biopharma company focused on the development of nicotinic receptor agonists for the treatment of asthma and other inflammatory diseases, has appointed Martin Driscoll chief executive officer. Mr Driscoll was previously CEO and a director of Javelin Pharmaceuticals and will succeed Dr Luc Vachon, who is leaving the company to pursue other business ventures.
Hospira's CEO and COO to step down
Hospira's CEO Christopher Begley and chief operational officer Terrence Kearney are to resign from their positions, having both served at the company since its foundation in 2004.
Company Information
- Industry
- Biotechnology
-
Pharmaceuticals
-
Drug Delivery
- Nasal
-
Drug Delivery
- Therapeutic Areas
- Neurology, Nervous System
- Alias(es)
- Intrac Inc.
- Ownership
- Private
- Headquarters
-
Worldwide
-
North America
-
USA
-
USA
-
North America
- Parent & Subsidiaries
- Pfizer Inc.
- Senior Management
-
Stephen J Tulipano, CFO
Daniel B Carr, MD, Pres. & CMO
John C Taylor, VP, Bus. Dev. - Contact Info
-
Javelin Pharmaceuticals Inc.
Phone: (617) 349-4500
125 CambridgePark Dr.
Cambridge, MA 02140
USA
You must sign in to use this functionality
Authentication.SignIn.HeadSignInHeader
Email Company
All set! This article has been sent to my@email.address.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
DCD.EmailPopout.Notice